Home Article ResMed CEO sells 400,000 shares

ResMed CEO sells 400,000 shares

ResMed CEO sells 400,000 shares

Also Noted

Default Author Head Shot

By HME News Staff

Updated Wed February 6, 2013

SAN DIEGO - ResMed CEO and Executive Chairman Peter Farrell sold 400,000 shares at an average price of $46.98 on Jan. 30, according to an article from Nasdaq.com. Farrell made the sale the same day CMS announced a reimbursement cut of, on average, 45% as part of Round 2 of competitive bidding, which drove ResMed's stock price to drop more than 6%.

Comments

To comment on this post, please log in to your account or set up an account now.